2024-03-28T23:12:36Zhttp://repisalud.isciii.es/oai/requestoai:repisalud.isciii.es:20.500.12105/133262023-10-30T10:45:17Zcom_20.500.12105_2116com_20.500.12105_2052com_20.500.12105_2051col_20.500.12105_2117
00925njm 22002777a 4500
dc
Riad, Abanoub
author
Schünemann, Holger
author
Attia, Sameh
author
Peričić, Tina Poklepović
author
Žuljević, Marija Franka
author
Jürisson, Mikk
author
Kalda, Ruth
author
Lang, Katrin
author
Morankar, Sudhakar
author
Yesuf, Elias Ali
author
Mekhemar, Mohamed
author
Danso-Appiah, Anthony
author
Sofi-Mahmudi, Ahmad
author
Pérez-Gaxiola, Giordano
author
Dziedzic, Arkadiusz
author
Apóstolo, João
author
Cardoso, Daniela
author
Marc, Janja
author
Moreno-Casbas, Teresa
author
Wiysonge, Charles Shey
author
Qaseem, Amir
author
Gryschek, Anna
author
Tadić, Ivana
author
Hussain, Salman
author
Khan, Mohammed Ahmed
author
Klugarova, Jitka
author
Pokorna, Andrea
author
Koščík, Michal
author
Klugar, Miloslav
author
2021
Coronavirus disease (COVID-19) vaccine-related side effects have a determinant role in the public decision regarding vaccination. Therefore, this study has been designed to actively monitor the safety and effectiveness of COVID-19 vaccines globally.
A multi-country, three-phase study including a cross-sectional survey to test for the short-term side effects of COVID-19 vaccines among target population groups. In the second phase, we will monitor the booster doses' side effects, while in the third phase, the long-term safety and effectiveness will be investigated. A validated, self-administered questionnaire will be used to collect data from the target population; Results: The study protocol has been registered at ClinicalTrials.gov, with the identifier NCT04834869.
CoVaST is the first independent study aiming to monitor the side effects of COVID-19 vaccines following booster doses, and the long-term safety and effectiveness of said vaccines.
Int. J. Environ. Res. Public Health 2021; 18(15), 7859
http://hdl.handle.net/20.500.12105/13326
34360156
10.3390/ijerph18157859
1660-4601
International Journal of Environmental Research and Public Health
COVID-19
Cohort studies
Cross-sectional studies
Drug-related side effects and adverse reactions
Health personnel
Mass vaccination
Prevalence
COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines' Side Effects.